{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:23Z","timestamp":1793817743447,"version":"4.6.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cmet.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:38:53Z","timestamp":1765381133000},"page":"208-227.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade"],"prefix":"10.1016","volume":"38","author":[{"given":"Ming-Ming","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ran","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-Peng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Jiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-6934","authenticated-orcid":false,"given":"Zhi-Ren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2025.11.009_bib1","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cmet.2025.11.009_bib2","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC Review Topic of the Week","volume":"74","author":"Ball","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cmet.2025.11.009_bib3","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1093\/eurheartj\/ehab618","article-title":"Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis","volume":"42","author":"Dolladille","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cmet.2025.11.009_bib4","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa458","article-title":"Immune checkpoint inhibitor-induced thyroid dysfunction is associated with higher body mass index","volume":"105","author":"Pollack","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2025.11.009_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180516","article-title":"Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer","volume":"134","author":"G\u00f3mez-Banoy","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2025.11.009_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmet.2025.11.009_bib7","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.cmet.2025.11.009_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2025.11.009_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","volume":"5","author":"Strauss","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cmet.2025.11.009_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2025.11.009_bib11","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/s42255-022-00631-8","article-title":"Adipocyte IRE1alpha promotes PGC1alpha mRNA decay and restrains adaptive thermogenesis","volume":"4","author":"Chen","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2025.11.009_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2025.11.009_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/db08-1220","article-title":"Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss","volume":"58","author":"Gregor","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2025.11.009_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/ni.3709","article-title":"The metabolic ER stress sensor IRE1alpha suppresses alternative activation of macrophages and impairs energy expenditure in obesity","volume":"18","author":"Shan","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cmet.2025.11.009_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167359","article-title":"Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis","volume":"133","author":"Awasthi","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2025.11.009_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni.1857","article-title":"TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages","volume":"11","author":"Martinon","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cmet.2025.11.009_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","article-title":"Adipose-tissue plasticity in health and disease","volume":"185","author":"Sakers","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2025.11.009_bib18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2025.11.009_bib19","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.cmet.2024.08.009","article-title":"PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders","volume":"36","author":"Luo","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2025.11.009_bib20","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2025.11.009_bib21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/emboj.2011.52","article-title":"The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis","volume":"30","author":"Zhang","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.cmet.2025.11.009_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1083\/jcb.201701049","article-title":"p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1","volume":"217","author":"He","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cmet.2025.11.009_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15548627.2023.2247300","article-title":"Interplay of energy metabolism and autophagy","volume":"20","author":"Feng","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.cmet.2025.11.009_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cmet.2025.11.009_bib25","article-title":"Phosphoregulation of Ire1 RNase splicing activity","volume":"5","author":"Prischi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00163-w","article-title":"Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity","volume":"8","author":"Cao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib27","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/annrheumdis-2013-203755","article-title":"Free fatty acids: potential proinflammatory mediators in rheumatic diseases","volume":"74","author":"Frommer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cmet.2025.11.009_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.R067595","article-title":"The role of ER stress in lipid metabolism and lipotoxicity","volume":"57","author":"Han","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cmet.2025.11.009_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cmet.2014.08.010","article-title":"Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages","volume":"20","author":"Kratz","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2025.11.009_bib31","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.celrep.2017.08.096","article-title":"Metabolically activated adipose tissue macrophages perform detrimental and beneficial functions during diet-induced obesity","volume":"20","author":"Coats","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmet.2025.11.009_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cell.2007.10.057","article-title":"Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation in nonconventional RNA splicing","volume":"132","author":"Lee","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2025.11.009_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19974-5","article-title":"Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands","volume":"11","author":"Ferri","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.cell.2017.10.040","article-title":"A J-protein co-chaperone recruits BiP to monomerize IRE1 and repress the unfolded protein response","volume":"171","author":"Amin-Wetzel","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cmet.2025.11.009_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s41590-021-01023-y","article-title":"Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation","volume":"22","author":"Yao","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cmet.2025.11.009_bib36","article-title":"RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cmet.2025.11.009_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.8","article-title":"MyD88-BLT2-dependent cascade contributes to LPS-induced interleukin-6 production in mouse macrophage","volume":"47","author":"Lee","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cmet.2025.11.009_bib38","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.185.9.1661","article-title":"Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn","volume":"185","author":"Meng","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cmet.2025.11.009_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112693","article-title":"Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2","volume":"42","author":"Wu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmet.2025.11.009_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","article-title":"FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2025.11.009_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38605-3","article-title":"ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"287","author":"Urano","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cmet.2025.11.009_bib43","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/emboj.2013.183","article-title":"Toll-like receptor-mediated IRE1alpha activation as a therapeutic target for inflammatory arthritis","volume":"32","author":"Qiu","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.cmet.2025.11.009_bib44","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41590-021-01032-x","article-title":"The IRX(3)some factor in macrophages","volume":"22","author":"Moynagh","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cmet.2025.11.009_bib45","article-title":"CD146 associates with Gp130 to control a macrophage pro-inflammatory program that regulates the metabolic response to obesity","volume":"9","author":"Duan","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cmet.2025.11.009_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4528","article-title":"Hepatic IRE1alpha regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARalpha axis signalling","volume":"5","author":"Shao","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib47","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cmet.2025.11.009_bib48","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.30066","article-title":"TRUSS exacerbates NAFLD development by promoting I\u03baB\u03b1 degradation in mice","volume":"68","author":"Yu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2025.11.009_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2016.03.006","article-title":"Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis","volume":"65","author":"Gao","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cmet.2025.11.009_bib50","article-title":"METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33558-5","article-title":"Decoding the spatial chromatin organization and dynamic epigenetic landscapes of macrophage cells during differentiation and immune activation","volume":"13","author":"Lin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/ATVBAHA.123.320612","article-title":"Macrophage-derived GSDMD plays an essential role in atherosclerosis and cross talk between macrophages via the mitochondria-STING-IRF3\/NF-\u03baB axis","volume":"44","author":"Fan","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cmet.2025.11.009_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07358-9","article-title":"Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity","volume":"9","author":"Kubota","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2025.11.009_bib54","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","article-title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis","volume":"580","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2025.11.009_bib55","first-page":"273","article-title":"Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cmet.2025.11.009_bib56","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41556-023-01133-9","article-title":"Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function","volume":"25","author":"Wu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cmet.2025.11.009_bib57","article-title":"Alphafold 3.0: the AI protein predictor gets an upgrade","author":"Thompson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2025.11.009_bib58","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa2111380","article-title":"Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma","volume":"386","author":"Doki","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2025.11.009_bib59","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1200\/JCO.21.02885","article-title":"Five-year outcomes with pembrolizumab versus chemotherapy as first-line therapy in patients with non-small-cell lung cancer and programmed death ligand-1 tumor proportion score \u2265 1% in the KEYNOTE-042 Study","volume":"41","author":"de Castro","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib62","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.20.02212","article-title":"Nivolumab and ipilimumab as maintenance therapy in extensive-disease small-cell lung cancer: CheckMate 451","volume":"39","author":"Owonikoko","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib63","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1200\/JCO.22.00620","article-title":"Pembrolizumab versus placebo as second-line therapy in patients from Asia with advanced hepatocellular carcinoma: a randomized, double-blind, phase III trial","volume":"41","author":"Qin","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib64","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1200\/JCO.19.02446","article-title":"Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1\u2012positive, advanced non\u2012small-cell lung cancer in the KEYNOTE-010 Study","volume":"38","author":"Herbst","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100341","article-title":"Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia","volume":"7","author":"Cao","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.cmet.2025.11.009_bib66","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jtho.2019.01.006","article-title":"Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced NSCLC: CheckMate 078 randomized phase III clinical trial","volume":"14","author":"Wu","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2020.11.010","article-title":"Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma","volume":"144","author":"Robert","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cmet.2025.11.009_bib68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.34532","article-title":"KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC","volume":"153","author":"Ren","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cmet.2025.11.009_bib69","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2016.71.8023","article-title":"Overall survival in patients with advanced melanoma who received nivolumab versus investigator\u2019s choice chemotherapy in CheckMate 037: a randomized, controlled, open-label phase III trial","volume":"36","author":"Larkin","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib70","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.20.01605","article-title":"Five-year outcomes from the randomized, phase III trials CheckMate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer","volume":"39","author":"Borghaei","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib71","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.19.03091","article-title":"Randomized double-blind phase II study of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients with metastatic urothelial cancer","volume":"38","author":"Galsky","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cmet.2025.11.009_bib72","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J. Clin. Oncol."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413125004930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413125004930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:30:09Z","timestamp":1783027809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413125004930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1550413125004930"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2025.11.009","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}